THE BALANCE

Private admissions

Let’s talk about your next step.

Speak with our admissions team about treatment for you or someone you care about.

Your admissions team

Jil Moore
Jil MooreClient Relations Director
Cynthia Nakhle
Cynthia NakhleAdmissions Manager
Abdullah Boulad, Founder & CEO

Prefer to speak with our founder?

Abdullah Boulad · Founder & CEO

Clinical resource

One Gulf, Six Different Measures: Why More Mental-Health Care Is Not Yet a Comparable Recovery Story

A six-country examination of Gulf mental-health evidence: consultations, workforce, screening, student studies and rehabilitation capacity answer different questions about care and recovery.

Clinically reviewed byDr. Sarah Boss, MD
Stone residence with a swimming pool, lawn and palm trees

A consultation in Saudi Arabia, a screening in Qatar, a specialist in Abu Dhabi, and a rehabilitation bed in Oman all describe healthcare activity. They do not describe the same result. The Gulf’s changing services deserve more than a crisis headline or a ranking built from incompatible percentages. Families need to understand the pathway between first contact and sustained recovery.

Key findings

More than 54,000: Saudi virtual addiction consultations reported for 2024. [1]

81%: growth in Abu Dhabi’s mental-health workforce since 2022, reported in August 2026. [2]

More than one million: each of anxiety and depression screenings recorded by Qatar’s PHCC in 2023. Categories overlap. [3]

46 of 56: analyzed intervention participants finding a Kuwait student program useful, not a clinical recovery rate. [4]

Six countries, six different evidence questions

Selected Gulf evidence, not a national ranking
LocationObservationWhat it describes
Saudi ArabiaOver 54,000 virtual addiction consultations, 2024Service activity [1]
UAE: Abu Dhabi640 professionals, reported August 2026Capacity in one emirate [2]
QatarOver one million screenings per condition, 2023PHCC screening activity [3]
Kuwait46 of 56 intervention respondents found support usefulExperience in a selected student study [4]
Bahrain310-student symptom survey, collected 2021Exploratory self-reported experiences [5]
Oman30 first-phase beds and 25 planned second-phase bedsOpened and proposed capacity, separately [6]

The observations have different populations, periods, and units. They cannot be added as a count of people treated or converted into a country recovery score.

Saudi Arabia: adherence is not remission

The Saudi announcement reported 2,468 people initiating treatment alongside consultation volume and 80% adherence. It did not define that adherence percentage as a long-term clinical outcome. [1]

A confidential delivery channel may matter to a prospective patient. The source does not identify which users were executives or affluent, or establish why they chose it.

The next useful report would connect assessed needs, delivered treatment, engagement, health changes, and later follow-up. That would show more than repeated contacts alone.

Abu Dhabi: a framework is the start of measurement

The August 2026 announcement identified 143 facilities, including thirteen specialized centers, and nineteen adopted patient-outcome indicators. It describes measurement as well as staffing growth. [2]

Families would benefit from knowing who contributes to those indicators, when outcomes are measured, and how differing needs are handled.

A workforce percentage is not a proxy for those results. Equally, the absence of results in one announcement does not prove no outcome measurement exists. Abu Dhabi must also remain distinct from UAE-wide figures.

Qatar: screening events are not unique patients

Recorded anxiety and depression screenings in Qatar PHCCAnxiety screenings: 199465 in 2018 and 1119006 in 2023. Depression: 187653 and 1107551. Categories overlap and do not count unique diagnosed patients. Bars start at zero.Screening counts, not unique patientsAnxiety 2018199,465Anxiety 20231,119,006Depression 2018187,653Depression 20231,107,5510500,0001,000,000

The observations cover 2018 to 2023. The paper appeared online November 29, 2025 despite a 2026 volume designation. Source: Al Abdulla and colleagues. [3]

The next questions concern positive screens, assessment, appointment offers, attendance, and benefit. One person may complete both instruments or appear in several years.

For a family, screening should begin a clinical conversation rather than settle a diagnosis. For an evaluator, the valuable comparison follows those stages without inflating the number of people reached.

Kuwait: the positive response came from a subset

Participant counts in the Kuwait student study240 initially allocated, 98 in final analysis, 56 in its intervention group, and 46 of those finding the program useful. These are different study denominators, not stages of clinical recovery.Study participation, not a recovery funnelInitial sample240Final analysis98Final intervention group56Intervention: found useful460100200

The 46-of-56 usefulness response should not become a recovery claim for all 240 participants. Source: Alotaibi and colleagues, May 2025. [4]

The study also examined symptom outcomes. Usefulness is a separate measure, and attrition qualifies how widely the final findings apply.

The wider relevance is methodological, not a claim that students represent executives. A family evaluating support should ask who remained in the analysis and what the outcome actually measured.

Bahrain and Oman add different evidence again

Bahrain’s 310-student survey collected responses in October 2021 and appeared in July 2026. It examined self-reported bowel symptoms and perceived psychological stress using a questionnaire that was not a validated diagnostic tool. It was symptom screening, not national prevalence or treatment evaluation. [5]

Its practical theme is considering physical and psychological difficulties together without inferring cause from association.

Oman’s April 2026 announcement describes thirty first-phase rehabilitation beds and twenty-five detoxification beds planned for phase two. Capacity status must remain explicit. Admissions and later recovery would require another dataset. [6]

A genuine Gulf comparison starts with one question

A shared study could examine time to help-seeking, receipt of appropriate assessment, continuity, or a defined clinical outcome. It should not begin by collecting whichever dramatic percentage exists in each country.

Citizenship, residence, language, income, and wealth need separate definitions. A senior title does not establish net worth, and a wealthy household does not establish each member’s control over care.

Country samples and uncertainty must support country comparisons. A pooled convenience survey can describe experiences without producing reliable national rankings.

Common definitions would make the comparison useful

Proposed common evidence framework
QuestionMinimum common definition
Who needed care?Population, assessment, severity, and period
Who obtained it?Actual treatment received, not only an offered contact
Who improved?Comparable outcome and baseline measures
Did improvement last?Follow-up, subsequent care, and recurrence definitions
Who was missing?Eligibility, participation, and follow-up counts
Does it apply to this family?Clinical needs, language, residence, and pathway context

Apparent differences should not automatically be attributed to culture, stigma, or quality. Those explanations require evidence of their own.

The international-care choice is not a country contest

A family comparing Gulf and overseas care needs suitable pathways, not an abstract contest between destinations. National workforce data cannot establish an individual program’s fit, and an attractive overseas setting cannot establish better results.

Ask which patients the provider treats, how progress is measured, and who remains responsible when the person travels. An accepted handover matters more than a long referral list.

Privacy should support consent-based care. An employer, relative, or adviser may assist without acquiring unrestricted access to clinical information.

These questions apply equally to THE BALANCE. This report offers no proprietary success rate or conclusion that overseas care outperforms local services.

What the evidence cannot tell us

This is a selected evidence review, not an audit of every Gulf service. It does not establish that outcome measurement is absent, and it does not define a national or HNW recovery rate. The different indicators are useful when their roles remain clear.

The bottom line

Compare the pathway before comparing the percentage. Gulf services show meaningful developments, but the promoted numbers should explain what happens between contact and patient benefit. More access matters. Transparent, comparable outcomes would make that access easier to evaluate.

For journalists

Key finding: the six-country evidence describes activity, capacity, screening, experience, or exploratory symptoms rather than one regional recovery measure.

Important caveat: a regional ranking assembled from these indicators would have no defensible clinical meaning.

Suggested attribution: THE BALANCE comparison of selected published GCC evidence.

Methodology and sources

This selective narrative review retains publication and observation dates. Charts reproduce study counts. No composite ranking, original HNW survey, or patient-level regional dataset was created.

  1. Saudi Ministry of Health. Virtual addiction consultations during 2024. June 26, 2025.
  2. Department of Health, Abu Dhabi. Services and workforce. August 3, 2026.
  3. Al Abdulla and colleagues. PHCC screening and integration. November 29, 2025.
  4. Alotaibi and colleagues. Kuwait student stress-management study. May 12, 2025.
  5. Alalwan. Bahrain student symptoms and stress. July 20, 2026; survey October 2021.
  6. Oman Ministry of Health. Al Salwa Hospital opening. April 16, 2026.
What this includes
01

Clinical context

Clear information is framed around complex and co-occurring presentations.

02

Individual factors

Assessment remains essential because needs and risks differ from person to person.

03

Next steps

A confidential conversation can help clarify the most appropriate route forward.

Not sure where the situation fits?

Your admissions team

Jil Moore
Jil MooreClient Relations Director
Cynthia Nakhle
Cynthia NakhleAdmissions Manager

A confidential first conversation can help clarify the presentation and whether our setting is appropriate.

THE BALANCE
A PLACE TO BEGIN

Ask about our care